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reductions cn the composite endpoint of death, repeat MI. ischemic target vessel revas- 
cularization (TVR), and disabling stroke (3.0% vs. 1.3%, p=O.Ol), largely due to a 
decrease in ischemic TVR (2.4% vs. 0.6%, p=O.O025). Abciximab also reduced early 
subacute thrombosis (1 .O% vs. O.l%, p=O.O06). Among 1703 pts in the U.S., mean times 
of hospital D/C in abcx and non-abcx treated pts were 4.9 + 2.7 days vs. 5.4+ 3.5 days 
respectively, p<O.OOl, and total mean in-hospital costs for the 2 groups were $13,413 
(abcx) vs. $13,000 (no abcx), p=O.13. In the first 7 days following hospital D/C, there 
were no significant differences relative to abcx treatment regarding the composite end- 
point (0.8% vs. 0.3%, p=NS) or its individual elements, nor were differences in major or 
minor bleeding observed. 
Conclusions- Adjunctive abciximab therapy during primary PCI is associated with 
reduced early adverse ischemic outcomes that may facilitate early hospital D/C and 
effect cost sawngs. However, standard times to D/C after primary PCI are now so short 
that efforts to further accelerate DIG with abciximab were for the most part not feasible, 
and cost savings were not realized. 
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Surgery Operations 
Ronald M. Weintraut$ Donald S. Likosky, Cathy S. Ross, Bruce J. Leavitt, Charles A. 
Marnn, David J. Malenka, Louis R. Caplan, Yvon R. Baribeau. Dawd C. Charlesworth, 
Felix Hernandez, Gerald T. O’Connor, Beth Israel Deaconess Medical Center, Boston, 
MA, Northern New England Cardiovascular Disease Study Group, Lebanon, NH 
Background:We previously ldenttfied patient and disease characteristics associated 
with risk of stroke following isolated CABG We hypothesized that duration of cardiopul- 
monary bypass (CPB) is an independent risk factor for stroke. 
Methods We collected data prospectively from 29,406 consecutive patients undergoing 
CABG with CPB between 1992 2000. Stroke was defined as a new focal neurological 
deficit lasting >24 hours. Patients were divided into quartiles by duration of CPB. We 
excluded patients requiring return to CPB and CPB ~30 mln and >=230 min. Direct stan- 
dardization was used to adjust for pre-operative risk factors. 
Results There were 460 (1.56%) strokes. Risk of stroke was twice as great (2.3% vs. 
1 .O%) in the highest quartile than in the lowest (ptrendc 0.001). This increased risk per- 
sisted after adjusting for pre-operative risk factors. 
Conclusion: Increasing duration of CPB was significantly associated with risk of stroke, 
independent of pre-operative risk factors. Possible mechanisms include damage to blood 
elements, increased embolic burden, and difficulty in separation from CPB. 
Table 1: Crude vs. Adjusted Rates of Stroke by Quartile of Cardiopulmonary 
Bypass Duration 
Rates of Strokes 
Quartiles of Pumptime (min) Crude Adjusted” 
<70 1.03 1.13 
70-66 1.23 1.24 
67-106 1.60 1.50 
109-230 2.19 2.06 
*Adjusted for age, sex, diabetes, vascular disease, renal failure or creatinine ,2ms/dl, 
acuity, ejection fraction ~40% 
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871-4 Impact of Coronary Artery Bypass Graft Versus 
Percutaneous Coronary Intervention With Stent on 
Disease-Specific Functional Status in Diabetic and 
Nondiabetic Patients: Results From the SOS Trial 
Zefeng Zhang, Elizabeth M. Mahoney, Rod H. Stables, Jean Booth, Fiona Nugara, John 
A. Spertus, William S. Weintrauh, Emory University School of Medicine, Atlanta, GA 
Background. Previous results from the SOS trial showed a significant benefit of CABG vs 
PCI with Stent on Seattle Angina Questionnaire (SAQ) scores at 6 and 12 mo. Results 
from the BARI trial suggested that for patients (pts) with diabetes (DM), CABG yields 
superior Survival relative to PTCA. The influence of DM on SAQ scores as well as 
whether the relative benefit of CABG vs PCI on SAQ scores applies to DM and non-DM 
pts is not known. Methods. The SOS trial randomized 966 pts with multivessel disease 
from 11196 to 12/99 to CABG (74 DM and 426 non-DM) or PCI with stent (68 DM and 420 
non-DM). We examined the influence of DM on 3 SAQ domains: physlcal limitation (PL), 
angina frequency (AF), and quality of ltfe (QOL) at baseline. 6 and 12 mo. as well as 
whether the relative effect of CABG vs PCI on 6 and 12 mo SAQ scores varied bv DM 
status. SAQ scores range from 0 to 100; higher scores indicate better functioning. All 
analvses were adiusted for slaniflcant covariates. Results. For DM and Non-DM Dts. PL. 
AF and QOL improved significantly after both CABG and PCI at 6 and 12 mo. and CABG 
showed greater gains compared to PCI for most SAQ domains (Non-DM: pcO.01 for 6 
mo PL, AF and QOL. ~~0.02 for 1 yr PL, AF and p=O.O9 for lyr QOL; DM, p=O.O2 for 6 
mo AF, p=O.O9 for 6 mo PL, p>O.lO for other domains). No DM by treatment interaction 
for any SAQ domains was found. Conclusion. While pts with DM tended to have lower 
improvements in PL. CABG appears to confer the same benefits compared to PCI in DM 
and non-DM pts. 
Mean changes for 3 SAQ domams (p-value for DM*treatment mtrractmn) 
SAQ scales 
PL DM 
Non-DM 
AF DM 
Non-DM 
QOL DM 
Non-DM 
6mo 
CABG PCI p CABG 
16.6 10.5 0.55 13.9 
20.3 16.4 16.4 
35.4 27.1 0.66 34.7 
36.2 29.6 37.5 
29.6 26.5 0.65 33.7 
33.2 26.0 35.1 
1 Yr 
PCI p 
10.0 0.94 
14.7 
31.6 0.75 
33.4 
30.1 0.61 
32.5 
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Anthony C. DeFranco, William L. Meengs. Richard McNamara, John G. McGinnity, Kirit 
P&l, David Share, Arthur Riba, Mauro Moscucci, Blue Cross Blue Shield of Michigan 
CardiovascularConsortium, University of Michigan Hospitals, Ann Arbor, Ml 
Background Recent studies have shown a relationship between anemia and in-hospital 
mortality in patients undergoing CABG and with acute myocardial infarction (AMI). The 
prognostic implication of anemia in patients undergoing percutaneous coronary intewen- 
tion (PCI) is unknown. We evaluated the relationship between pre-procedural hemoglo- 
bin (Hgb) level and PCI mortality in a quality controlled regional database. 
Methods: ClInical, procedural, and outcome data on 26,313 consecutwe PCI were pro- 
spectively collected in a consortium of 9 hospitals. Pre-procedure Hgb levels were avail- 
able for 93.3% of patients. Patients were divided into quintiles based on pre-procedural 
Hgb level (g/dl):Ql(6.6-12.3), Q2(12.3-13.5), Q3(13.5-14.4), Q4(14.4-15.4), Qs(l5.4. 
20.1). The primary endpoint was in-hospital mortality. 
Results The in-hospital mortality rate was significantly higher !n 01 when compared to 
other quintiles (Table), (OR 2.4,CI 2.0.3.0,p~O.OOOl). After adjustment for comorbidities, 
Ql remalned an independent predlctor of in-hospital mortality (adjusted OR 1.37,95% Cl 
1.1.1.7,p<O.O2). Analysis of patients undergoing PCI < 24 hours of AMI revealed a higher 
mortality rate I” 01 and Q2 when compared with Q3-05 (pcO.05) (Table). 
Conclusions: Lower pre-procedural Hgb levels are associated with higher in-hospital 
mortality following PCI, particularly in patients within 24 hours of AMI. Whether optimiza- 
tlon of Hgb levels prior to PCI may be of clinical benefit remains to be determined. 
Hgb quintile All PCI patients (n=24,554) PCI with AMI < 24hr (n=3,737) 
Ql 2.9% 11.5% 
Q2 1.6% 9.0% 
1 1% 
Q4 0.9% 4.8% 
05 1.1% 3.6% 
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871-6 Hospital Percutaneous Coronary Intervention Volume 
and Patient Mortality: Is the ACC/AHA Volume Minimum 
Appropriate? 
Andrew J. Epstein Saif S. Rathore, Kevin G. Volpp, Harlan M. Krumholz, Yale University 
School Of Medicine, New Haven. CT, Universih/ of Pennsvlvania Wharton School of 
Bustness. Philadelphia. PA 
Background: To minimize mortality, current ACCIAHA guidelines recommend hospitals 
offering percutaneous coronary interventions (PCls) perform at least 400 PCls annually. 
The appropriateness of this threshold to contemporary practice is unknown. 
Methods: We used data from the Agency for Healthcare Research and Quality 1999 
Nationwide Inpatient Sample, an administrative database of all discharges from a ran- 
dom sample of US hospitals, to assess the association between hospital PCI volume and 
in-hospital mortality. The sample included all PCI recipients age 18 years or older from 
214 hospitals in 22 states (n=ll5,910). Hospitals were grouped by annual PCI volume: 
low (5-l 99, n=55), medium (200.399, n=46). high (400-999, n=60), and very high (21000. 
n=33). We examined the crude association between hospital PCI volume and in-hospital 
mortality using chi-square tests. Multivariate logistic regression with generalized estimat- 
ing equations was used to evaluate the independent association between PCI volume 
